Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials, a critical competency for legal and business professionals in the biopharmaceutical arena.
Attend ACI’s Hatch-Waxman and BPCIA Proficiency Series from October 10-26, a virtual three-week
program designed to provide new lawyers and executives for the life sciences industry with a solid
foundation for understanding the essentials as well as the intricacies of Hatch-Waxman and BPCIA
litigation and regulation. This year’s co-chairs include Li Feng, Ph.D. (Finnegan) and Rachel Pernic
Waldron (RMSS Legal).
This series will provide an in-depth review of Hatch-Waxman and the BPCIA along with other IP basics
relative to small molecules and biologics. This program will lay the necessary foundation to understand
the dynamics of the applicable patent life cycles for biopharmaceutical products and business
development plans.
To learn more visit https://bit.ly/3Diz6wl.
Save 10% with the PM360 promo code: D10-999-PM36024
